The Daily Children and Covid: Your Questions, Answered
Aug 23, 2021
Emily Anthes, a health and science reporter for The New York Times, tackles parents' pressing questions about kids and COVID-19. She discusses the anxieties surrounding school reopenings and the implications of the Delta variant. Vaccine trials for younger children and potential side effects come under scrutiny, aiming to provide clarity. The conversation also highlights long COVID in children and the ongoing need for research, while offering insights into effective school safety measures amidst rising infection rates.
AI Snips
Chapters
Transcript
Episode notes
Vaccine Trial Updates
- Emily Anthes explains that trials for children aged 5-11 are ongoing, and data hasn't been submitted to the FDA yet.
- The FDA requested expanded trials to assess rare side effects like myocarditis (heart inflammation), particularly in young males.
Parent Concern about Vaccine Delay
- A parent from Lakeland, Florida expresses concern over the delay in COVID-19 vaccine approval for children under 12.
- They seek clarity on the timeline and reasons behind the extended process.
COVID-19 Severity in Children
- COVID-19 generally affects children less severely than adults, often presenting as mild cold-like symptoms.
- Serious cases and hospitalizations are rare, around 1%, with an even lower death rate of 0.01%.